0.3531

9.69% -0.0379

After Hours: .36 0.0069 +1.95%

Biorestorative Therapies Inc (BRTX)

Overview News Price History Financials Discussions Forecast Stock Split

Biorestorative Therapies Inc stock is traded at $0.3531, with a volume of 763.24K. It is down -9.69% in the last 24 hours and up +83.71% over the past month. BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Previous Close:

$0.391

Open:

$0.3909

24h Volume:

763.24K

Relative Volume:

0.07

Market Cap:

$9.00M

Revenue:

$357.90K

Net Income/Loss:

$-11.06M

P/E Ratio:

-0.3152

EPS:

-1.1201

Net Cash Flow:

$-11.90M

1W Performance:

-10.47%

1M Performance:

+83.71%

6M Performance:

-67.31%

1Y Performance:

-78.20%

1-Day Range:

$0.3506

$0.3925

1-Week Range:

$0.3496

$0.42

52-Week Range:

$0.1593

$1.89

Biorestorative Therapies Inc Stock (BRTX) Company Profile

Name

Biorestorative Therapies Inc

Sector

Healthcare (1107)

Industry

Biotechnology (621)

Phone

(631) 760-8100

Address

40 MARCUS DRIVE, MELVILLE

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

BRTX's Discussions on Twitter

Compare BRTX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BRTX Biorestorative Therapies Inc	0.3531	9.96M	357.90K	-11.06M	-11.90M	-1.1201
VRTX Vertex Pharmaceuticals Inc	453.17	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.73	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	878.49	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	281.90	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	156.58	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Biorestorative Therapies Inc Stock (BRTX) Latest News

Jun 13, 2026

BioRestorative Therapies, Inc. Enters Revolving Credit Agreement with Bowery Group LLC – 12% Interest, NASDAQ: BRTX – Minichart - Minichart

Jun 13, 2026

BioRestorative Revamps Board Following New Loan Agreement - TipRanks

Jun 13, 2026

Jun 12, 2026

BioRestorative Therapies Finalizes Executive Agreement with R&D VP - TipRanks

Jun 12, 2026

BioRestorative Therapies enters $1 million revolving loan and appoints new directors - Investing.com Nigeria

Jun 12, 2026

BioRestorative (NASDAQ: BRTX) sets 3-year deal with R&D leader Silva - Stock Titan

Jun 12, 2026

BioRestorative Therapies, Inc. Enters Into $1,000,000 Revolving Loan Agreement With Bowery Group LLC - marketscreener.com

Jun 12, 2026

BioRestorative Therapies (NASDAQ: BRTX) adds $1M revolver and installs lender-backed directors - Stock Titan

Jun 12, 2026

BRTX Q1 2026 Earnings: Narrowed Loss Beats Estimates as Cash Management ContinuesEarnings Season Outlook - newsline.com

Jun 12, 2026

Jun 05, 2026